Physician profile
Rull James Toussaint
NPI 1598924920
$802,486.76
in general payments reported to CMS, 2019-2025
15 companies · $187K in 2025
The $187K reported for 2025 was more than what 98% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $41K · 2020: $25K · 2021: $106K · 2022: $101K · 2023: $151K · 2024: $191K · 2025: $187K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $320K · Consulting Fee: $156K · Travel and Lodging: $49K · Food and Beverage: $4,725.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $320,093.98 |
| Consulting Fee | $156,051.80 |
| Travel and Lodging | $48,901.94 |
| Food and Beverage | $4,725.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medline Industries Lp | $621,462.70 | 2019-2025 | Medline Industries, INC., Medline, Pending |
| Medshape, INC. | $74,981.99 | 2019-2021 | |
| Restor3d, INC. | $56,145.98 | 2021-2025 | |
| International Life Sciences | $38,795.74 | 2022-2024 | Flexband |
| Kuros Biosciences USA, INC | $7,663.85 | 2025 | Magnetos |
| Wright Medical Technology, INC. | $1,769.86 | 2019 | |
| Novastep INC. | $737.43 | 2021 | |
| Stryker Corporation | $397.78 | 2021-2024 | Prostep, Prophecy, Graftjacket |
| Integra Lifesciences Corporation | $146.71 | 2019-2021 | |
| Sanara Medtech INC. | $134.51 | 2023 | Celleraterx |
| Cgg Medical INC | $132.20 | 2024 | |
| Paragon 28, INC. | $103.20 | 2023 | Portfolio |
| Horizon Therapeutics Plc | $14.81 | 2019 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$1,169,912.36 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rull James Toussaint listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.